Equities

IVF Hartmann Holding AG

IVF Hartmann Holding AG

Actions
  • Price (CHF)146.00
  • Today's Change1.00 / 0.69%
  • Shares traded997.00
  • 1 Year change+35.19%
  • Beta0.4325
Data delayed at least 15 minutes, as of Nov 12 2024 16:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

IVF HARTMANN Holding AG (IVF) is a Switzerland-based holding company engaged in the field of medical supplies. The Company's product range includes bandages, rheumatism plasters, baby products, feminine hygiene, cotton wool, first aid, diagnostics equipment, X-ray protection clothing, among others. The Company’s main clients usually are hospitals, doctors, surgery centers, care centers, pharmacies, drugstores, wholesalers and corporate medical centers. The Company also offers consulting services, on-site or in classrooms, related to the usage of its products. The Company's activities are divided into research and development, distribution logistics, production planning, purchase and four production segments: Coating; Medical Products; Elastic Bandages, and Hygiene Products. It also operates subsidiaries located in Switzerland.

  • Revenue in CHF (TTM)152.90m
  • Net income in CHF17.64m
  • Incorporated1883
  • Employees298.00
  • Location
    IVF Hartmann Holding AGVictor-von-Bruns-Strasse 28NEUHAUSEN AM RHEINFALL 8212SwitzerlandCHE
  • Phone+41 526743111
  • Fax+41 526727441
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Detection Technology Oyj-93.85bn-93.85bn191.18m464.00--2.76----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
Medistim ASA43.67m8.11m201.98m152.0024.876.2419.984.635.555.5529.8722.121.130.74617.483,599,204.0021.0522.9325.5328.5279.1278.2518.5820.642.75--0.018175.257.0010.06-8.9112.720.03314.87
Onward Medical NV0.00-32.99m209.41m99.00--8.23-----1.09-1.090.000.60790.00----0.00-66.40-55.70-79.20-61.60-------79,513.95----0.4855---34.62---10.40--32.59--
BICO Group AB182.93m-63.90m212.95m828.00--0.9085--1.16-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Tristel Plc47.53m7.35m235.06m213.0032.236.3822.554.950.1350.1350.87140.68180.98121.815.74--15.189.3217.7510.7680.0880.7515.4711.093.04--0.1532109.3516.459.8945.469.9910.1319.53
Nyxoah SA4.77m-49.72m278.61m147.00--2.84--58.42-1.72-1.720.1663.040.03660.55692.3034,618.53-38.20-23.73-42.88-25.9861.7562.42-1,042.52-1,469.594.95-45.270.1822--40.99---38.39--100.58--
COLTENE Holding AG238.80m12.34m326.27m1.19k26.483.2616.991.372.062.0639.8916.731.271.386.06198,668.906.5510.4811.7018.7464.9062.685.177.470.861910.180.342179.94-9.133.54-54.05-6.81-7.72-7.79
Synektik SA133.09m17.10m332.09m164.0019.439.0117.412.509.329.3272.5420.092.0316.347.224,043,567.0026.0410.2441.6515.7926.6522.8612.858.851.2813.970.090947.00167.81--409.18------
IVF Hartmann Holding AG152.90m17.64m348.00m298.0019.732.4614.862.287.357.3563.7258.840.87883.148.52502,947.4010.147.2912.068.9055.2153.2911.548.303.95--0.005852.16-1.792.0934.951.49-14.8326.82
Guerbet SA775.40m30.75m353.53m2.92k11.880.96694.220.45592.512.5166.4230.820.81280.54935.56282,958.603.031.404.961.8678.5876.023.731.821.163.850.507357.824.30-0.0993158.05-12.615.23-10.07
Stratec SE235.12m9.40m366.25m1.46k38.981.7113.331.560.82360.823620.6118.740.56051.275.32164,609.702.247.072.858.2027.0427.324.009.700.92693.860.401140.81-4.636.88-55.293.30-2.16-7.68
Ion Beam Applications SA437.09m7.37m383.09m1.84k50.144.3620.820.87640.26890.268915.993.090.77212.152.70234,517.101.301.556.014.3234.1935.231.692.380.63723.770.399264.8318.6710.74-250.40---8.06--
medmix AG479.70m-1.80m412.21m2.70k--0.88417.160.8593-0.05-0.0511.3511.300.47783.405.58180,474.00-0.09962.06-0.12272.4932.5836.38-0.20854.161.062.210.436167.701.991.40-97.41-64.3612.01--
RaySearch Laboratories AB (publ)91.66m12.28m431.65m403.0045.278.9112.664.714.414.4132.9122.410.57014.503.112,901,244.007.641.2911.801.8890.4890.5713.402.551.17--0.393769.0021.1610.26243.060.7648-1.31--
CellaVision AB59.87m12.20m468.78m228.0038.437.5230.087.836.306.3030.9132.190.78491.917.263,233,162.0015.9915.3018.4518.2466.9969.0320.3819.982.151,358.860.044110.185.9413.1710.128.0030.458.45
Surgical Science Sweden AB68.08m16.06m476.57m265.0029.681.2822.987.003.873.8716.4390.020.16951.497.353,224,027.004.004.494.264.7868.5170.0623.5923.753.46--0.000.0010.0168.1424.47--38.57--
Data as of Nov 12 2024. Currency figures normalised to IVF Hartmann Holding AG's reporting currency: Swiss Franc CHF

Institutional shareholders

1.50%Per cent of shares held by top holders
HolderShares% Held
UBS Asset Management Switzerland AGas of 30 Sep 202417.55k0.73%
Principal Verm�gensverwaltung AGas of 28 Jun 20244.44k0.19%
Z�rcher Kantonalbank (Investment Management)as of 30 Aug 20244.09k0.17%
Deka Investment GmbHas of 30 Jun 20243.23k0.14%
BlackRock Asset Management Schweiz AGas of 03 Oct 20241.71k0.07%
Pictet Asset Management SAas of 30 Jun 20241.58k0.07%
Ante Asset Management AGas of 30 Sep 20241.45k0.06%
Credit Suisse AGas of 30 Aug 20241.08k0.05%
Dimensional Fund Advisors Ltd.as of 31 Aug 2024485.000.02%
DWS CH AGas of 30 Sep 2024466.000.02%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.